I want to discuss a high-stakes question around micro/nanoplastics (MNPs) in brains and the idea of a looming plastic debt / threshold problem.

Context: Matt Campen and colleagues have discussed striking claims like ~0.5% of the brain (mass fraction) being microplastic and exponential increases over time (e.g., ~1.5× every ~8 years, depending on the specific analysis). Many people criticize aspects of the measurement pipeline (e.g., pyrolysis-based methods, contamination, polymer identification, etc.), but Campen has argued the trendlines persist, including for non-PE/PP components. Meanwhile, the quality of MNP studies overall is often inconsistent and contested.

Regardless of the exact headline number, the key meta-point is: environmental microplastic levels have been increasing rapidly (possibly exponentially) for decades.

Hypothesis (plastic debt framing)

If environmental MNP levels are increasing roughly exponentially, then human tissue loads may also be increasing over time, potentially with lag + saturation, but still with a nonlinear trajectory.

This leads to a scary dynamic: we might not get a clear early warning signal (in population-level cognition/neurology) until tissue loads cross some functional threshold, after which harm becomes obvious and hard to reverse.

Questions

1) Do environmental exponentials imply human exponentials?

• What is the best evidence for time trends in human MNP loads (blood, placenta, lung, brain)?
• Are there plausible reasons tissue loads would not track the environment (homeostatic clearance, behavioral changes, filtration, regulatory changes), or would track it with strong damping?

2) Measurement controversies: what can we trust?

• What are the strongest critiques of pyrolysis-based quantification, and what controls address them?
• Which methods are currently most credible for tissue MNPs (µFTIR, Raman, pyrolysis-GC/MS, microscopy + spectroscopy, etc.)?
• How should studies report uncertainty and contamination controls to make trend claims believable?

3) Thresholds and early warning

If the “threshold” story is right, how do we estimate the threshold before we see clear population-level IQ/neuroplasticity changes?

Possible approach: use natural experiments / high-variance sentinel species and human subpopulations.

4) Seabirds as sentinel cohorts

There’s substantial variation in MNP loads across seabird species and ecologies.

• Can we use seabirds to estimate dose–response relationships for neurobehavior, reproduction, immune function, or other performance metrics?
• Which seabird datasets are best and how do they measure MNP loads?

5) Human heterogeneity as signal

In humans, MNP loads may differ by:

• geography (SE Asia, coastal vs inland)
• diet/seafood exposure
• occupation/airborne exposure
• health status (e.g., dementia, BBB integrity, membrane integrity)

Do existing datasets already have enough variance to test associations with cognition/neurodegeneration biomarkers?

6) ‘Most human value’ framing

If neuroplasticity / cognition are downstream of subtle membrane/BBB/inflammation effects, then MNPs could threaten a large fraction of what we care about.

• What biomarkers should we track now (BBB permeability, neuroinflammation, lipid peroxidation markers, white matter integrity, etc.) alongside MNP load?

What I’m looking for

• The best primary papers and critiques on brain MNP measurements (including Campen et al.)
• Time series or cohort data that can test exponential trends
• Sentinel-species work that could help estimate functional thresholds
• A rigorous framework for “plastic debt” analogous to climate debt: delayed harm, nonlinear thresholds, and irreversibility

If you think the exponential trend is an artifact, I’m equally interested — but I’d like the strongest argument and what evidence would falsify the threshold concern.